Triapine Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 3-AP, 3-Apct, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, OCX-0191, OCX-191, OCX191, PAN-811

Filter by location:

Duarte, California1 trial

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

City of Hope Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.